Verastem, Inc.
VSTMNASDAQHealthcare● Active
$3.67
$-0.04(-1.08%)
Market Cap$254382017
P/E Ratio—
52W High$11.25
52W Low$3.58
Verastem, Inc. (VSTM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
VSTM · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.46
Est. -$0.46 · +0.0%
Revenue
$0.02B
Est. $0.02B · -12.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▼ Miss Revenue✓ 2-Quarter EPS Beat Streak
VSTM reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.45 | — | — | — | $0.02B | — |
| — Q2 FY2026 | May 7, 2026 | -$0.46 | -$0.46 | +0.0% | $0.02B | $0.02B | -12.9% |
| ▲ Q1 FY2026 | Mar 4, 2026 | -$0.49 | -$0.39 | +20.4% | $0.02B | $0.02B | +3.7% |
| ▼ Q4 FY2025 | Nov 4, 2025 | -$0.51 | -$1.35 | -164.7% | $0.01B | $0.02B | -32.0% |
| ▲ Q3 FY2025 | Aug 7, 2025 | -$0.85 | -$0.39 | +54.1% | $0.00B | $0.01B | -62.5% |
| ▼ Q2 FY2025 | May 13, 2025 | -$0.72 | -$0.96 | -33.3% | — | $0.00B | — |
| ▼ Q1 FY2025 | Mar 20, 2025 | -$0.81 | -$1.33 | -64.2% | $0.01B | $0.00B | +6550.7% |
| ▲ Q4 FY2024 | Nov 6, 2024 | -$0.71 | -$0.60 | +15.5% | — | $0.00B | — |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.45
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026
EPS Actual
-$0.46
EPS Est.
-$0.46
EPS Surpr.
+0.0%
Revenue
$0.02B
Q1 FY2026
Mar 4, 2026Beat
EPS Actual
-$0.39
EPS Est.
-$0.49
EPS Surpr.
+20.4%
Revenue
$0.02B
Q4 FY2025
Nov 4, 2025Miss
EPS Actual
-$1.35
EPS Est.
-$0.51
EPS Surpr.
-164.7%
Revenue
$0.01B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
-$0.39
EPS Est.
-$0.85
EPS Surpr.
+54.1%
Revenue
$0.00B
Q2 FY2025
May 13, 2025Miss
EPS Actual
-$0.96
EPS Est.
-$0.72
EPS Surpr.
-33.3%
Revenue
—
Q1 FY2025
Mar 20, 2025Miss
EPS Actual
-$1.33
EPS Est.
-$0.81
EPS Surpr.
-64.2%
Revenue
$0.01B
Q4 FY2024
Nov 6, 2024Beat
EPS Actual
-$0.60
EPS Est.
-$0.71
EPS Surpr.
+15.5%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.37 | $-0.32 | $-0.29 | 1 |
| Q3 FY2027 | $-0.37 | $-0.32 | $-0.29 | 1 |
| Q2 FY2027 | $-0.38 | $-0.33 | $-0.30 | 1 |
| Q1 FY2027 | $-0.38 | $-0.33 | $-0.30 | 1 |
| Q4 FY2026 | $-0.39 | $-0.34 | $-0.31 | 1 |
| Q3 FY2026 | $-0.45 | $-0.39 | $-0.36 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.1B | $0.1B | 2 |
| Q3 FY2027 | $0.0B | $0.0B | $0.1B | 2 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +0.0% | $6.01 | $5.66 | -5.82% |
| ▲ Q1 FY2026 | Mar 4, 2026 | +20.4% | $5.68 | $5.81 | +2.29% |
| ▼ Q4 FY2025 | Nov 4, 2025 | -164.7% | $9.90 | $7.91 | -20.10% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +54.1% | $5.72 | $5.62 | -1.75% |
| ▼ Q2 FY2025 | May 13, 2025 | -33.3% | $7.29 | $7.46 | +2.33% |
| ▼ Q1 FY2025 | Mar 20, 2025 | -64.2% | $6.98 | $6.82 | -2.29% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +15.5% | $3.74 | $3.87 | +3.48% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +70.8% | $2.22 | $2.24 | +0.90% |
Q2 FY2026-5.82%
Report Date
May 7, 2026
EPS Beat/Miss
+0.0%
Price Before
$6.01
Price After
$5.66
Q1 FY2026+2.29%
Report Date
Mar 4, 2026
EPS Beat/Miss
+20.4%
Price Before
$5.68
Price After
$5.81
Q4 FY2025-20.10%
Report Date
Nov 4, 2025
EPS Beat/Miss
-164.7%
Price Before
$9.90
Price After
$7.91
Q3 FY2025-1.75%
Report Date
Aug 7, 2025
EPS Beat/Miss
+54.1%
Price Before
$5.72
Price After
$5.62
Q2 FY2025+2.33%
Report Date
May 13, 2025
EPS Beat/Miss
-33.3%
Price Before
$7.29
Price After
$7.46
Q1 FY2025-2.29%
Report Date
Mar 20, 2025
EPS Beat/Miss
-64.2%
Price Before
$6.98
Price After
$6.82
Q4 FY2024+3.48%
Report Date
Nov 6, 2024
EPS Beat/Miss
+15.5%
Price Before
$3.74
Price After
$3.87
Q3 FY2024+0.90%
Report Date
Aug 8, 2024
EPS Beat/Miss
+70.8%
Price Before
$2.22
Price After
$2.24
Avg Beat Reaction-0.18%
Avg Miss Reaction-6.69%
Beat Rate5 / 8 quarters
Largest Move-20.10% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: VSTM ends December
Verastem, Inc. (VSTM) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.46 (in line with the analyst consensus of $-0.46). VSTM has beaten EPS estimates for 2 consecutive quarters. The next VSTM earnings date is expected around September 1, 2026.
Each quarter, investors track VSTM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. VSTM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
VSTM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
VSTM earnings · 4 questionsVerastem, Inc.'s next earnings report is expected around September 1, 2026. VSTM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; VSTM historically reports after market close (AMC).
VSTM earnings datewhen is VSTM earningsVSTM next earnings datewhen does VSTM report earningsVSTM earnings calendar
▸ Source: FMP · Verastem, Inc. SEC filings · US GAAP · Verastem, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026